Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ELANE | P08246 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.31 |
| ▸ | TSHR | P16473 | 3/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | RAB9A | P51151 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3025266 | 1.00 | ELANE (0.32) | ELANEKDM4ETSHRHSD17B10MEN1 | |
| SCHEMBL3024912 | 0.92 | KDM4E (0.33) | KDM4EHSD17B10ALDH1A1HPGD | |
| SCHEMBL3024910 | 0.92 | KDM4E (0.33) | KDM4EHSD17B10ALDH1A1HPGD | |
| SCHEMBL3028114 | 0.89 | ELANE (0.31) | ELANEKDM4ETSHRHSD17B10HPGD | |
| SCHEMBL3028113 | 0.89 | ELANE (0.31) | ELANEKDM4ETSHRHSD17B10HPGD | |
| SCHEMBL3796312 | 0.89 | ELANE (0.31) | ELANE | |
| SCHEMBL3796313 | 0.89 | ELANE (0.31) | ELANE | |
| SCHEMBL3015915 | 0.88 | PKM (0.34) | ELANETSHRMAPTALDH1A1 | |
| SCHEMBL3015918 | 0.88 | PKM (0.34) | ELANETSHRMAPTALDH1A1 | |
| SCHEMBL3015521 | 0.87 | KDM4E (0.32) | ELANEKDM4ETSHRHSD17B10MEN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100190794-A1 | Herbicidally Active Composition | BASF SE (DE) | 2010-07-29 | — | — | US | claimed |
| US-20100152047-A1 | Piperazine Compounds Whith a Herbicidal Action | BASF SE (DE) | 2010-06-17 | — | — | US | claimed |
| US-20100190794-A1 | Herbicidally Active Composition | BASF SE (DE) | 2010-07-29 | — | — | US | disclosed |
| US-20100152047-A1 | Piperazine Compounds Whith a Herbicidal Action | BASF SE (DE) | 2010-06-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100152047-A1 | Piperazine Compounds Whith a Herbicidal Action | CBR3, CBR1, CNPY2 | ELANE 3135/4885KDM4E 4015/4885TSHR 846/4885 |
| US-20100190794-A1 | Herbicidally Active Composition | ECI1, ACLY, SQOR | ELANE 4638/4885KDM4E 2283/4885TSHR 1271/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.